These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 33870858)
1. The screening of immune-related biomarkers for prognosis of lung adenocarcinoma. Liu Z; Sun D; Zhu Q; Liu X Bioengineered; 2021 Dec; 12(1):1273-1285. PubMed ID: 33870858 [TBL] [Abstract][Full Text] [Related]
2. Heat shock factor 5 correlated with immune infiltration serves as a prognostic biomarker in lung adenocarcinoma. Aizemaiti R; Wu Z; Tang J; Yan H; Lv X Int J Med Sci; 2021; 18(2):448-458. PubMed ID: 33390814 [TBL] [Abstract][Full Text] [Related]
3. An integrated analysis of prognostic and immune infiltrates for hub genes as potential survival indicators in patients with lung adenocarcinoma. Xu Z; Wang S; Ren Z; Gao X; Xu L; Zhang S; Ren B World J Surg Oncol; 2022 Mar; 20(1):99. PubMed ID: 35354488 [TBL] [Abstract][Full Text] [Related]
4. Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level. Wang W; Ren S; Wang Z; Zhang C; Huang J Int Immunopharmacol; 2020 Jan; 78():106077. PubMed ID: 31812070 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value and immune infiltration of a novel stromal/immune score-related P2RY12 in lung adenocarcinoma microenvironment. Yu L; Cao S; Li J; Han B; Zhong H; Zhong R Int Immunopharmacol; 2021 Sep; 98():107734. PubMed ID: 34175738 [TBL] [Abstract][Full Text] [Related]
6. Decreased HLF Expression Predicts Poor Survival in Lung Adenocarcinoma. Wang Z; Li X; Chen H; Han L; Ji X; Wang Q; Wei L; Miao Y; Wang J; Mao J; Zhang Z Med Sci Monit; 2021 May; 27():e929333. PubMed ID: 33979320 [TBL] [Abstract][Full Text] [Related]
7. Analysis of genes associated with prognosis of lung adenocarcinoma based on GEO and TCGA databases. Yu Y; Tian X Medicine (Baltimore); 2020 May; 99(19):e20183. PubMed ID: 32384511 [TBL] [Abstract][Full Text] [Related]
8. High Expression of Deng H; Huang Y; Wang L; Chen M Biomed Res Int; 2020; 2020():2071593. PubMed ID: 33134373 [TBL] [Abstract][Full Text] [Related]
9. NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis. Liu XS; Zhou LM; Yuan LL; Gao Y; Kui XY; Liu XY; Pei ZJ Front Immunol; 2021; 12():724741. PubMed ID: 34335635 [TBL] [Abstract][Full Text] [Related]
10. A gene expression-based immune signature for lung adenocarcinoma prognosis. Wang L; Luo X; Cheng C; Amos CI; Cai G; Xiao F Cancer Immunol Immunother; 2020 Sep; 69(9):1881-1890. PubMed ID: 32372138 [TBL] [Abstract][Full Text] [Related]
11. Prognostic model of lung adenocarcinoma constructed by the CENPA complex genes is closely related to immune infiltration. Zhou H; Bian T; Qian L; Zhao C; Zhang W; Zheng M; Zhou H; Liu L; Sun H; Li X; Zhang J; Liu Y Pathol Res Pract; 2021 Dec; 228():153680. PubMed ID: 34798483 [TBL] [Abstract][Full Text] [Related]
12. Estimation of Hub Genes and Infiltrating Immune Cells in Non-Smoking Females with Lung Adenocarcinoma by Integrated Bioinformatic Analysis. Li J; Wang B; Li X; Zhu Y Med Sci Monit; 2020 Jul; 26():e922680. PubMed ID: 32669531 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of CCR2 as an immune indicator in lung adenocarcinoma: A study based on tumor-infiltrating immune cell analysis. Wan Y; Wang X; Liu T; Fan T; Zhang Z; Wang B; Zhang B; Tian Z; Mao T; Gong Z; Zhang L Cancer Med; 2021 Jun; 10(12):4150-4163. PubMed ID: 33949150 [TBL] [Abstract][Full Text] [Related]
14. Construction of the optimization prognostic model based on differentially expressed immune genes of lung adenocarcinoma. Zhai Y; Zhao B; Wang Y; Li L; Li J; Li X; Chang L; Chen Q; Liao Z BMC Cancer; 2021 Mar; 21(1):213. PubMed ID: 33648465 [TBL] [Abstract][Full Text] [Related]
15. TOX correlates with prognosis, immune infiltration, and T cells exhaustion in lung adenocarcinoma. Guo L; Li X; Liu R; Chen Y; Ren C; Du S Cancer Med; 2020 Sep; 9(18):6694-6709. PubMed ID: 32700817 [TBL] [Abstract][Full Text] [Related]
16. Correlation between prognostic indicator AHNAK2 and immune infiltrates in lung adenocarcinoma. Zheng M; Liu J; Bian T; Liu L; Sun H; Zhou H; Zhao C; Yang Z; Shi J; Liu Y Int Immunopharmacol; 2021 Jan; 90():107134. PubMed ID: 33168407 [TBL] [Abstract][Full Text] [Related]
17. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma. Li J; Liu X; Cui Z; Han G Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582 [TBL] [Abstract][Full Text] [Related]
18. Microarray analysis of the expression profile of immune-related gene in rapid recurrence early-stage lung adenocarcinoma. Liu J; Yang X; Zhang L; Yang B; Rao W; Li M; Dai N; Yang Y; Qian C; Zhang L; Xiao H; Wang D J Cancer Res Clin Oncol; 2020 Sep; 146(9):2299-2310. PubMed ID: 32556504 [TBL] [Abstract][Full Text] [Related]
19. Integrated bioinformatics analysis reveals CDK1 and PLK1 as potential therapeutic targets of lung adenocarcinoma. Li S; Li H; Cao Y; Geng H; Ren F; Li K; Dai C; Li N Medicine (Baltimore); 2021 Aug; 100(32):e26474. PubMed ID: 34397869 [TBL] [Abstract][Full Text] [Related]
20. Junctional Adhesion Molecule-Like Protein (JAML) Is Correlated with Prognosis and Immune Infiltrates in Lung Adenocarcinoma. Fang L; Yu W; Yu G; Zhong F; Ye B Med Sci Monit; 2022 Jan; 28():e933503. PubMed ID: 35034089 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]